Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Genome engineering is a technique in which a DNA is inserted, deleted, modified or replaced in the genome of a living organism. Research and development activities are conducted in genome engineering for the development of novel technologies. For instance, in 2017, Synthego Corporation launched a CRISPR Pioneers Program to expand genome engineering research. Researchers are majorly focusing on developing treatments for cancer and rare diseases with the help of genome engineering tools such as CRISPER. Many genome technologies are under trial for treatment of such diseases, and are expected to receive approvals in the near future.
Market Dynamics
Development of novel technologies in genome engineering field is expected to significantly drive growth of the global genome engineering market in the near future. For instance, in 2017, Merck KGaA— Germany-based company—developed a new genome editing tool dubbed 'proxy-CRISPR', providing access to previously inaccessible microenvironments of the genome by modification of chromatin modifications. In 2017, Benson Hill Biosystems, Inc.—an agricultural technology company—launched its latest CRISPR 3.0, to increase innovators’ access to gene editing. CRISPR 3.0 is a latest innovative genomics tool, which is expected to improve crop performance. Development of such novel technologies by major key players is expected to create a conducive environment for growth of market.
Furthermore, increasing strategic collaborations by major key players for genome engineering technologies is also expected to drive market growth. For instance in 2015, ToolGen, Inc.—a South Korea-based company—collaborated with Thermo Fisher Scientific and licensed its CRISPR/Cas9 intellectual property portfolio to Thermo Fisher Scientific. This license agreement has strengthened the relationship between ToolGen and Thermo Fisher in the area of genome editing. In 2014, Cellectis Bioresearch and Thermo Fisher Scientific entered into a strategic collaboration agreement covering the uses of TAL nucleases under the brand name TALEN. As per the agreement, Thermo Fisher Scientific is granted a worldwide license under Cellectis’ rights to the TAL nucleases outside the therapeutic field. Thermo Fisher will market TALEN for these applications under its Life Technologies brand. In 2014, Bluebird Bio, Inc. acquired Precision Genome Engineering (Pregenen) at US$ 139.9 Mn. This acquisition has helped the company to use Pregenen’s MegaTALs, originally developed by Precision Genome Engineering. In 2014, Biogen Idec and Sangamo BioSciences, Inc. entered into a collaboration agreement for the development of treatment of Hemoglobinopathies. According to the collaboration, Biogen Idec will use Sangamo's proprietary zinc finger nuclease (ZFN) genome-editing technology.
Key features of the study:
This report provides in-depth analysis of genome engineering market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global genome engineering market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., CRISPR Therapeutics AG, Intellia Therapeutics, Inc., Editas Medicine, Inc., Sangamo Therapeutics, Inc., Bluebird Bio, Inc., Cellectis S.A., and Merck Group.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global genome engineering market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the genome engineering market
Detailed Segmentation:
Global Genome Engineering Market, By Technology :
CRISPR
TALEN
ZFN
Others
Global Genome Engineering Market, By Application:
Cell Line Engineering
Genetic Engineering
Global Genome Engineering Market, By End User:
Biotechnology & Pharmaceutical Companies
Research Institutes
Contract Research Organization
Global Genome Engineering Market, By Geography:
North America
By Technology :
CRISPR
TALEN
ZFN
Others
By Application:
Cell Line Engineering
Genetic Engineering
By End User:
Biotechnology & Pharmaceutical Companies
Research Institutes
Contract Research Organization
By Country:
U.S.
Canada
Europe
By Technology :
CRISPR
TALEN
ZFN
Others
By Application:
Cell Line Engineering
Genetic Engineering
By End User:
Biotechnology & Pharmaceutical Companies
Research Institutes
Contract Research Organization
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Technology :
CRISPR
TALEN
ZFN
Others
By Application:
Cell Line Engineering
Genetic Engineering
By End User:
Biotechnology & Pharmaceutical Companies
Research Institutes
Contract Research Organization
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Technology :
CRISPR
TALEN
ZFN
Others
By Application:
Cell Line Engineering
Genetic Engineering
By End User:
Biotechnology & Pharmaceutical Companies
Research Institutes
Contract Research Organization
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
By Technology :
CRISPR
TALEN
ZFN
Others
By Application:
Cell Line Engineering
Genetic Engineering
By End User:
Biotechnology & Pharmaceutical Companies
Research Institutes
Contract Research Organization
By Country:
GCC
Israel
Rest of Middle East
Africa
By Technology :
CRISPR
TALEN
ZFN
Others
By Application:
Cell Line Engineering
Genetic Engineering
By End User:
Biotechnology & Pharmaceutical Companies
Research Institutes
Contract Research Organization
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Thermo Fisher Scientific Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
CRISPR Therapeutics AG
Intellia Therapeutics, Inc.
Editas Medicine, Inc.
Sangamo Therapeutics, Inc.
Bluebird Bio, Inc.
Cellectis S.A.
Merck Group
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
? Research Objectives
? Assumptions
? Abbreviations
2. Market Purview
? Report Description
? Market Definition and Scope
? Executive Summary
? Market Snippet, By Technology
? Market Snippet, By Application
? Market Snippet, By End User
? Market Snippet, By Region
? Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
? Market Dynamics
? Drivers
? Restraints
? Market Opportunities
? PEST Analysis
? Key Developments
? Collaboration-Acquisition
? Porter's Five Forces Analysis
4. Global Genome Engineering Market, By Technology, 2015-2025 (US$ Mn)
? Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
? CRISPR
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
? TALEN
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
? ZFN
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
? Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
5. Global Genome Engineering Market, By Application, 2015-2025 (US$ Mn)
? Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
? Cell Line Engineering
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
? Genetic Engineering
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
6. Global Genome Engineering Market, By End User, 2015-2025 (US$ Mn)
? Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
? Biotechnology & Pharmaceutical Companies
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
? Research Institutes
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
? Contract Research Organization
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Mn)
7. Global Genome Engineering Market, By Region, 2015-2025 (US$ Mn)
? Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2016-2025
? North America
? Market Size and Forecast, By Technology, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2015-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? U.S.
? Canada
? Europe
? Market Size and Forecast, By Technology, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2015-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? U.K.
? Germany
? Italy
? France
? Spain
? Russia
? Rest of Europe
? Asia Pacific
? Market Size and Forecast, By Technology, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2015-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? China
? India
? Japan
? ASEAN
? Australia
? South Korea
? Rest of APAC
? Latin America
? Market Size and Forecast, By Technology, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2015-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? Brazil
? Mexico
? Argentina
? Rest of Latin America
? Africa
? Market Size and Forecast, By Technology, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2015-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? Central Africa
? South Africa
? North Africa
? Middle East
? Market Size and Forecast, By Technology, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2015-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2015-2025 (US$ Mn)
? GCC
? Israel
? Rest of Middle East
8. Competitive Landscape
? Heat Map Analysis
? Company Profiles
? Thermo Fisher Scientific Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? CRISPR Therapeutics AG
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Intellia Therapeutics, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Editas Medicine, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Sangamo Therapeutics, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Bluebird Bio, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Cellectis S.A.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Merck Group
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
9. Section
? References
? Research Methodology
? About us and Sales Contact
*Browse 47 market data tables and 42 figures on "Genome Engineering Market - Global forecast to 2025".
